Alembic Pharmaceuticals (India) Market Value

APLLTD Stock   1,042  4.00  0.39%   
Alembic Pharmaceuticals' market value is the price at which a share of Alembic Pharmaceuticals trades on a public exchange. It measures the collective expectations of Alembic Pharmaceuticals Limited investors about its performance. Alembic Pharmaceuticals is trading at 1041.85 as of the 22nd of November 2024, a 0.39 percent increase since the beginning of the trading day. The stock's open price was 1037.85.
With this module, you can estimate the performance of a buy and hold strategy of Alembic Pharmaceuticals Limited and determine expected loss or profit from investing in Alembic Pharmaceuticals over a given investment horizon. Check out Alembic Pharmaceuticals Correlation, Alembic Pharmaceuticals Volatility and Alembic Pharmaceuticals Alpha and Beta module to complement your research on Alembic Pharmaceuticals.
Symbol

Please note, there is a significant difference between Alembic Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alembic Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alembic Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Alembic Pharmaceuticals 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alembic Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alembic Pharmaceuticals.
0.00
12/03/2022
No Change 0.00  0.0 
In 1 year 11 months and 22 days
11/22/2024
0.00
If you would invest  0.00  in Alembic Pharmaceuticals on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Alembic Pharmaceuticals Limited or generate 0.0% return on investment in Alembic Pharmaceuticals over 720 days. Alembic Pharmaceuticals is related to or competes with NRB Industrial, Shivalik Bimetal, Reliance Industrial, Sportking India, Shyam Metalics, Rajnandini Metal, and Lakshmi Finance. Alembic Pharmaceuticals is entity of India More

Alembic Pharmaceuticals Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alembic Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alembic Pharmaceuticals Limited upside and downside potential and time the market with a certain degree of confidence.

Alembic Pharmaceuticals Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Alembic Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alembic Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Alembic Pharmaceuticals historical prices to predict the future Alembic Pharmaceuticals' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alembic Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1,0371,0391,146
Details
Intrinsic
Valuation
LowRealHigh
910.63913.111,146
Details
Naive
Forecast
LowNextHigh
1,0331,0361,038
Details
Earnings
Estimates (0)
LowProjected EPSHigh
9.009.009.00
Details

Alembic Pharmaceuticals Backtested Returns

Alembic Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0201, which signifies that the company had a -0.0201% return per unit of standard deviation over the last 3 months. Alembic Pharmaceuticals Limited exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alembic Pharmaceuticals' mean deviation of 1.76, and Risk Adjusted Performance of (0.01) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.5, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Alembic Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Alembic Pharmaceuticals is likely to outperform the market. At this point, Alembic Pharmaceuticals has a negative expected return of -0.0498%. Please make sure to confirm Alembic Pharmaceuticals' total risk alpha, as well as the relationship between the skewness and day median price , to decide if Alembic Pharmaceuticals performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.69  

Good predictability

Alembic Pharmaceuticals Limited has good predictability. Overlapping area represents the amount of predictability between Alembic Pharmaceuticals time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alembic Pharmaceuticals price movement. The serial correlation of 0.69 indicates that around 69.0% of current Alembic Pharmaceuticals price fluctuation can be explain by its past prices.
Correlation Coefficient0.69
Spearman Rank Test0.63
Residual Average0.0
Price Variance17.7 K

Alembic Pharmaceuticals lagged returns against current returns

Autocorrelation, which is Alembic Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Alembic Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Alembic Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Alembic Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Alembic Pharmaceuticals regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Alembic Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Alembic Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Alembic Pharmaceuticals stock over time.
   Current vs Lagged Prices   
       Timeline  

Alembic Pharmaceuticals Lagged Returns

When evaluating Alembic Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Alembic Pharmaceuticals stock have on its future price. Alembic Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Alembic Pharmaceuticals autocorrelation shows the relationship between Alembic Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Alembic Pharmaceuticals Limited.
   Regressed Prices   
       Timeline  

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Alembic Stock

Alembic Pharmaceuticals financial ratios help investors to determine whether Alembic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alembic with respect to the benefits of owning Alembic Pharmaceuticals security.